Surgical Oncology in District of Columbia
13 providers, $923,969 in total reported payments from drug and device makers. Ranked below by lifetime general payments.
Ranking high here usually means a consulting or royalty arrangement, not wrongdoing. Payments to device inventors and trial investigators are legal, disclosed, and concentrated in a small number of people — which is exactly why a list like this has a steep top and a long flat tail.
What Medicare pays surgical oncology clinicians in District of Columbia
Across 9 surgical oncology clinicians in District of Columbia who billed Original Medicare Part B in 2024, Medicare allowed $591,541 in total — an average of $65,727 each, of which $65,727 was for services and the rest for drugs administered in the office.
This is not a salary. The rest is what Medicare allowed for services these clinicians billed — Original Medicare fee-for-service only. It excludes Medicare Advantage, which now covers more than half of Medicare enrollees, along with Medicaid and every commercial insurer, so for most clinicians it is a fraction of their practice. It is also gross revenue: staff, rent, supplies and malpractice premiums all come out of it before anyone is paid. Anyone quoting a figure like this as physician pay is misreading it.
Ranked by reported payments
- 1Wayne FrederickWashington$831,773
- 2Mihir ShahWashington$84,157
- 3Danier MooreWashington$1,936
- 4Bonnie SunWashington$1,759
- 5Robin WilliamsWashington$1,365
- 6Waddah Al-RefaieWashington$1,094
- 7Victor GallWashington$598
- 8Quyen ChuWashington$442
- 9Joyce WongWashington$315
- 10Jeffrey PeltonWashington$276
- 11Mark StevesWashington$219
- 12Paul SugarbakerWashington$23
- 13Andrea Jordan HayesWashington$14